financetom
Business
financetom
/
Business
/
What's Going On With Chewy Stock Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Chewy Stock Monday?
Jul 1, 2024 4:10 AM

Chewy, Inc ( CHWY ) stock gained Monday in premarket trading after ‘Roaring Kitty’ Keith Gill disclosed a 6.6% passive stake in a 13G filing.

Last week, Roaring Kitty posted an image of a cartoon dog on the social media platform X, sending the stock price upwards, followed by a trading halt due to volatility. 

Gill, who initiated the meme-stock craze in 2021, recently revealed a significant position in GameStop Corp ( GME ) stocks and options through a screenshot shared on Reddit, Inc ( RDDT ) on June 2.

Chewy’s stock surged after it reported robust first-quarter results and announced a $500 million share repurchase program in late May.

The e-commerce retailer for pet supplies reported better-than-expected first-quarter 2024 results.

The pet care company reported adjusted EPS of $0.31, quashing the analyst consensus estimate of $0.07. It reported sales of $2.88 billion, up 3.1% Y/Y, above the analyst consensus of $2.85 billion.

Goldman Sachs raised its price target to $35, citing Chewy’s operational enhancements and increasing revenue growth.

Chewy stock surged over 22% last month.

Price Action: CHWY shares traded higher by 20.2% at $32.75 premarket at the last check Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
D.E. Shaw throws support to Mantle Ridge in Air Products board fight
D.E. Shaw throws support to Mantle Ridge in Air Products board fight
Nov 3, 2024
NEW YORK, Oct 24 (Reuters) - Hedge fund D.E. Shaw shifted course in its campaign for change at industrial gases company Air Products and is now supporting a rival activist's efforts instead of pressing ahead with its own board challenge, sources familiar with the matter said on Thursday. D.E. Shaw has said it no longer plans to nominate its own...
Update: Teck Down 6.8% as it Reports a Q3 Earnings Beat But Cuts Its Copper Production Forecast
Update: Teck Down 6.8% as it Reports a Q3 Earnings Beat But Cuts Its Copper Production Forecast
Nov 3, 2024
11:17 AM EDT, 10/24/2024 (MT Newswires) -- (Adds detail and analyst comment.) Teck Resources (TECK-B.TO, TECK) was last seen down 6.8% after the company on Thursday after the company reported a third-quarter profit that topped estimates but again lowered its guidance for copper production. Teck said its third-quarter adjusted earnings from operations, excluding most one-time items, rose to $314 million,...
National Bank of Canada Expects Cameco, Denison, NexGen to Benefit from Nuclear Power Revival
National Bank of Canada Expects Cameco, Denison, NexGen to Benefit from Nuclear Power Revival
Nov 3, 2024
11:20 AM EDT, 10/24/2024 (MT Newswires) -- National Bank of Canada said Wednesday that it expects uranium companies Cameco ( CCJ ) , Denison Mines (DML.TO) and NexGen Energy ( NXE ) to benefit from recent news about material investments by US tech companies in the nuclear industry. The bank expects Cameco ( CCJ ) to benefit the most given...
Casi Pharmaceuticals Says China Cleared Phase 1/2 Trial in Immune Thrombocytopenia
Casi Pharmaceuticals Says China Cleared Phase 1/2 Trial in Immune Thrombocytopenia
Nov 3, 2024
11:16 AM EDT, 10/24/2024 (MT Newswires) -- Casi Pharmaceuticals ( CASI ) said Thursday that the Center for Drug Evaluation of China's National Medical Products Administration has approved the conduct of a phase 1/2 clinical trial of CID-103 in adults with chronic immune thrombocytopenia. The China study is part of a global clinical trial approved by the US Food and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved